US president Donald Trump has announced an executive order aimed at reducing US prescription drug costs by 30-80%. The policy would align US drug prices with the lowest prices paid internationally and ...

While Prasad’s views may not align with many of the FDA’s traditional policies, they do fit into a broader MAHA agenda of ...

On a podcast, Casey Means said she became skeptical of traditional medicine while training at Oregon Health & Science ...

The United States Food and Drug Administration has chosen Dr Vinay Prasad to lead its Center for Biologics Evaluation and Research.